"Gilead Hungers for more Cancer Drug Deals"

http://www.fiercebiotech.com/story/gilead-hun...e=internal

" Oncology is entering an era where significant advances are going to be made, far above and beyond what's been made previously," John Milligan, Gilead's operations chief, told Bloomberg . "It's a field where there's always the possibility of acquiring other molecules and companies as their technology or pipelines mature. We're certainly keeping our eye on it."